![Antineoplastic Agent Methotrexate Sodium, Preservative Free 25 mg / mL Injection Single Dose Vial 2 mL - Suprememed Antineoplastic Agent Methotrexate Sodium, Preservative Free 25 mg / mL Injection Single Dose Vial 2 mL - Suprememed](https://www.suprememed.com/wp-content/uploads/2022/02/antineoplasticagentmethotrexatesodiumpreservativefree25mgmlinjtev00703367103ct10-595x595.jpg)
Antineoplastic Agent Methotrexate Sodium, Preservative Free 25 mg / mL Injection Single Dose Vial 2 mL - Suprememed
![These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953 These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-2.jpg&id=659365)
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953
![Methotrexat Teva solution 10ml 100 mg/ml methotrexat Cancer treatment Метотрексат Тева - Medicaments Methotrexat Teva solution 10ml 100 mg/ml methotrexat Cancer treatment Метотрексат Тева - Medicaments](https://ukrstore.com/media/catalog/product/cache/1/image/9df78eab33525d08d6e5fb8d27136e95/m/e/methotrexat_teva_solution_10ml_100_mg_ml_methotrexat_cancer_treatment_.jpg)